Walden Biosciences

Last updated: August 28, 2025

Blaine McKee, CEO
Blaine McKee, CEO
USA | Funding: $51M (+)

Website: https://www.waldenbiosciences.com/

Walden Biosciences develops drugs for kidney disease, taking a two-pronged approach: antibodies and small molecules.